Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: report of a virtual meeting, 17–18 May 2021

Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: report of a virtual meeting, 17–18 May 2021

This data-driven meeting assessed the advantages and disadvantages of changing the way in which recurrences are differentiated as reinfection or recrudescence following the treatment of uncomplicated Plasmodium falciparum malaria. This has implications for the evaluation of antimalarial efficacy in therapeutic efficacy studies (TESs), as well as in regulatory trials for the development of new antimalarial drugs.